Average annual cost of Parkinson's disease in Sao Paulo, Brazil, with a focus on disease-related motor symptoms

Página do item simplificado
dc.citation.volume12
dc.contributor.authorBovolenta, Tania M.
dc.contributor.authorde Azevedo Silva, Sonia Maria Cesar [UNIFESP]
dc.contributor.authorSaba, Roberta Arb [UNIFESP]
dc.contributor.authorBorges, Vanderci [UNIFESP]
dc.contributor.authorFerraz, Henrique Ballalai [UNIFESP]
dc.contributor.authorFelicio, Andre C.
dc.coverageAlbany
dc.date.accessioned2020-07-17T14:03:24Z
dc.date.available2020-07-17T14:03:24Z
dc.date.issued2017
dc.description.abstractBackground: Although Parkinson's disease is the second most prevalent neurodegenerative disease worldwide, its cost in Brazil - South America's largest country - is unknown. Objective: The goal of this study was to calculate the average annual cost of Parkinson's disease in the city of Sao Paulo (Brazil), with a focus on disease-related motor symptoms. Subjects and methods: This was a retrospective, cross-sectional analysis using a bottom-up approach (ie, from the society's perspective). Patients (N=260) at two tertiary public health centers, who were residents of the Sao Paulo metropolitan area, completed standardized questionnaires regarding their disease-related expenses. We used simple and multiple generalized linear models to assess the correlations between total cost and patient-related, as well as disease-related variables. Results: The total average annual cost of Parkinson's disease was estimated at US$5,853.50 per person, including US$3,172.00 in direct costs (medical and nonmedical) and US$2,681.50 in indirect costs. Costs were directly correlated with disease severity (including the degree of motor symptoms), patients' age, and time since disease onset. Conclusion: In this study, we determined the cost of Parkinson's disease in Brazil and observed that disease-related motor symptoms are a significant component of the costs incurred on the public health system, patients, and society in general.en
dc.description.affiliationHosp Israelita Albert Einstein, Ave Albert Einstein,627-701 Morumbi, BR-05651901 Sao Paulo, SP, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Neurol Dept, UNIFESP, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, UNIFESP, Dept Neurol, Sao Paulo, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Neurol Dept, UNIFESP, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent2095-2108
dc.identifierhttp://dx.doi.org/10.2147/CIA.S151919
dc.identifier.citationClinical Interventions In Aging. Albany, v. 12, p. 2095-2108, 2017.
dc.identifier.doi10.2147/CIA.S151919
dc.identifier.issn1178-1998
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55370
dc.identifier.wosWOS:000418375700001
dc.language.isoeng
dc.publisherDove Medical Press Ltd
dc.relation.ispartofClinical Interventions In Aging
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectParkinson's diseaseen
dc.subjecthealth economicsen
dc.subjectcost of illnessen
dc.subjecthealth evaluationen
dc.subjectcost analysisen
dc.titleAverage annual cost of Parkinson's disease in Sao Paulo, Brazil, with a focus on disease-related motor symptomsen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos